A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA

NCT06049342 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

BIOLOGICAL: NCR100 injection

Sponsor

Nuwacell Biotechnologies Co., Ltd.

Collaborators

[object Object]
[object Object]